Study links protein to MDS survival rate, progression to AML

10/6/2011 | MDSBeacon.com

Taiwanese researchers have discovered that people with myelodysplastic syndromes who have lower levels of the angiopoietin-1 protein were less likely to progress to acute myeloid leukemia and survived longer compared with patients who had higher levels of the protein. The protein plays a role in the formation of new blood vessels, according to the study published in the British Journal of Cancer.

View Full Article in:

MDSBeacon.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN